MS and Demyelinating Disorders

Latest News

February 26th 2020

NeurologyLive Launches "Updates to the MRI Protocol and Clinical Guidelines for MS" Video Series Along With the Consortium of Multiple Sclerosis Centers

By NeurologyLive® Staff

The multi-part series features a panel of 5 distiguished experts, discussing topics related to the updates to MRI and guidelines for multiple sclerosis treatment.

February 24th 2020

Ofatumumab sBLA Is Accepted for Treatment of Relapsing Multiple Sclerosis

By Alicia Bigica

February 23rd 2020

Final Thoughts on MRI Guidelines and Protocols

February 23rd 2020

Payer and Patient Education of the Standardized Examination

February 23rd 2020

Impact of Insurance on Scanning and Patient Care

Latest Videos

Early DMT Prescription in Radiologically Isolated Syndrome: Ilena George, MD

Importance of Evaluating Real-World Populations in MS: Allitia DiBernardo, MD

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

Investigating TNFα Inhibition and CNS Demyelination: Spencer Hutto, MD

Growing Multiple Sclerosis Treatment Knowledge: Luc Truyen, MD, PhD

Measuring MS Fatigue in a Real-World Setting: Allitia DiBernardo, MD

Investigating Disability and Onset Age in NMOSD: Gabrielle Macaron, MD

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

Final Thoughts: Improving QoL in Multiple Sclerosis

Optimistic Outlook in Treating Multiple Sclerosis

CME Content

Video

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Katherine Ruzhansky, MD, MS

Video

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD

Multimedia

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA, FASCO; Girish Dhall, MD

Video

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Abigail Schwaede, MD; Alexis Lizarraga, MD, MS

Multimedia

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

Video

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

Video

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

Michael Levy, MD, PhD; Jeffrey L. Bennett, MD, PhD; Eoin P. Flanagan, MB, BCh

More News

Barriers in Use of CMSC Protocol

February 23rd 2020

Developing International Protocols and Standardized Scanners

February 23rd 2020

PML Monitoring and Educating Technicians

February 23rd 2020

Maintaining a Consistent Protocol and Scanner for MS

February 23rd 2020

Treatment Modifications Based on Inflammatory Activity

February 23rd 2020

MS Diagnosis: McDonald Criteria and Gadolinium

February 23rd 2020

Role of Gadolinium and Central Vein Sign in MS Imaging

February 23rd 2020

Evolution of MS MRI Guidelines and Alignment With MAGNIMS

February 23rd 2020

FDA Approves Programmable Pump System for Spasticity, Revised Treatment Recommendations for Spinal Muscular Atrophy, OnabotulinumtoxinA Trial Results

ByNeurologyLive® Staff

February 22nd 2020

Neurology News Network for the week ending February 22, 2020.

Patients Switching to High Efficacy MS Therapy from Natalizumab Fare Better

ByMatt Hoffman

February 21st 2020

New data suggest a switch from natalizumab to a high efficacy disease-modifying therapy for patients with multiple sclerosis is more beneficial than switching to moderate efficacy therapy, including a lower risk of disease activity.

Prometra II Pump Approved for Use With Spasticity Treatment Baclofen

ByMatt Hoffman

February 19th 2020

The Prometra II offers a pressure-driven, valve-gated delivery mechanism that allows for novel programming modes of intermittent flow followed by periods of no flow—a feature unique to this device.

Amit Bar-Or, MD, FRCP: Next Steps in Treating Progressive MS

February 17th 2020

Amit Bar-Or, MD, FRCPC: The Argument for Early MS Treatment

February 17th 2020

NDA Green Lighted For Diazepam Buccal Film, Solanezumab and Gantenerumab Fail in Alzheimer Trial, Mind Moments Episode 7 Live

ByNeurologyLive® Staff

February 15th 2020

Neurology News Network for the week ending February 15, 2020.

Neurofilament Light Chain: Just How Far Can One Biomarker Go?

ByMatt Hoffman

February 14th 2020

Neurofilament light chain has emerged as a biomarker with utility across the breadth of neurology, but just how much can it actually help?

MS and Demyelinating Disorders

Latest News

Latest Videos

Early DMT Prescription in Radiologically Isolated Syndrome: Ilena George, MD

Importance of Evaluating Real-World Populations in MS: Allitia DiBernardo, MD

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

Investigating TNFα Inhibition and CNS Demyelination: Spencer Hutto, MD

Growing Multiple Sclerosis Treatment Knowledge: Luc Truyen, MD, PhD

Measuring MS Fatigue in a Real-World Setting: Allitia DiBernardo, MD

Investigating Disability and Onset Age in NMOSD: Gabrielle Macaron, MD

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

Final Thoughts: Improving QoL in Multiple Sclerosis

Optimistic Outlook in Treating Multiple Sclerosis

CME Content

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

More News

Barriers in Use of CMSC Protocol

Developing International Protocols and Standardized Scanners

PML Monitoring and Educating Technicians

Maintaining a Consistent Protocol and Scanner for MS

Treatment Modifications Based on Inflammatory Activity

MS Diagnosis: McDonald Criteria and Gadolinium

Role of Gadolinium and Central Vein Sign in MS Imaging

Evolution of MS MRI Guidelines and Alignment With MAGNIMS

FDA Approves Programmable Pump System for Spasticity, Revised Treatment Recommendations for Spinal Muscular Atrophy, OnabotulinumtoxinA Trial Results

Patients Switching to High Efficacy MS Therapy from Natalizumab Fare Better

Prometra II Pump Approved for Use With Spasticity Treatment Baclofen

Amit Bar-Or, MD, FRCP: Next Steps in Treating Progressive MS

Amit Bar-Or, MD, FRCPC: The Argument for Early MS Treatment

NDA Green Lighted For Diazepam Buccal Film, Solanezumab and Gantenerumab Fail in Alzheimer Trial, Mind Moments Episode 7 Live

Neurofilament Light Chain: Just How Far Can One Biomarker Go?

Unmet Needs and Final Thoughts on Treating MS

Drugs in Development for MS, Including Ofatumumab

Original Drugs to Treat MS

Review of Natalizumab for MS

Recent Approvals for MS: Cladribine and Diroximel Fumarate

Patient Selection for Alemtuzumab for Treatment of MS

EXPAND Clinical Trial of Siponimod for Treatment of MS

Rebound Management Strategies for MS Therapies

ASSESS Clinical Trial of Fingolimod for Treatment of MS

Recent Treatment Strategies Explored for Relapsing MS

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Phase 3 PROPEL Trial to Test Imeroprubart in Generalized Myasthenia Gravis

Ecopipam Shows Early and Sustained Tic Reduction in New Pediatric Tourette Syndrome Analyses

LRRK2 Inhibitor BIIB122 Fails to Slow Early-Stage Parkinson Disease

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype

Phase 1 Data Link ARV-102 LRRK2 Degradation to Oculomotor and CSF Biomarker Changes in Parkinson Disease